Alkermes plc

US$45.90As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALKSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (0.77%)
Div yield —
ROE (0.02%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM —
TSR TTM 49.51%
Mkt cap US$7.713B
ROIC (0.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$48
4.12%
(57.36%)
Hold 0|0|3|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.65
0.69
0.66
0.74
29.65%
28.91%
18.24%
23.55%
Revenue$M
583.4
582.0
567.8
560.4
14.01%
10.77%
4.47%
(1.77%)
Peers (US$7.713B)
Cap (US$)
PE
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
0.347
0.450
0.448
EBIT/Intx
0.697
0.081
0.092
Own earn%
(5.47)
(85.63)
(75.21)
Sh yield%
43.52
30.59
33.51
Owners
Insiders/Inst%
9.40
48.88
Short interest%
4.85
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
16–26
$1 testx
0.0
Incr. ROIC%
3